drugset
drugset / Trial / NCT05194579

Pharmacokinetic Comparability Study in Healthy Participants - PF-06881894 On-Body Injector Relative to Prefilled Syringe

NCT05194579 ↗

Phase 1 Completed 141 enrolled Pfizer
RandomizedCrossoverOpen-labelBasic science

Summary

This will be an open-label, randomized, 2-treatment, 2-period, crossover single-dose study in approximately 134 healthy adult participants. Participants will be randomized into 2 sequences of treatment as described in the following table of Intervention Groups and Duration.

Timeline

Start
2022-02-10
Primary completion
2022-08-10
Completion
2022-08-10

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-06881894 Unknown 6 mg Subcutaneous

Indications

No indication recorded.